GLAXF Stock | News | Quote | Stock Forum | Sunday, October 13,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
GlaxoSmithKline plc GLAXF Company Overview 

Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt1=Go!

Last Updated: Sunday, October 13, 2013 03:59:43 AM

GlaxoSmithKline plc GLAXF Current Price and Quotes
Last Price 24.68
Previous Close 25.15 Open 24.94
Daily Range 24.94 - 24.58 52wk Range 27.11 - 20.67
Volume 886 Dividend N/A
Average Vol (3m) 1,823 Yield N/A
GlaxoSmithKline plc GLAXF
Company Information

980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom

Website: http://www.gsk.com
Phone: +44 (0)20-8047-5000

GlaxoSmithKline plc GLAXF
Not Available

GlaxoSmithKline plc GLAXF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Dec 31, 2012 20-F
CIK 0001131399
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Jean-Pierre Garnier CEO
John Coombe CFO
Simon Bicknell Secretary
Company Directors

Not Available
Company Notes

Formerly=Glaxo Wellcome plc until 12-00. Glaxo Wellcome plc merged with SmithKline Beecham plc. prior to name change. Basis: 1.138 GlaxoSmithKline plc ADRs for each SmithKline Beecham plc ADR held
Formerly=Glaxo, PLC until 5-95
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

GlaxoSmithKline plc GLAXF
GLAXF Security Details Other Company Securities

Share Structure

Market Value1 $128,155,095,600 a/o Oct 11, 2013
Shares Outstanding 5,192,670,000 a/o Jun 30, 2010
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

GSK - LSE - London Stock Exchange - Qualified
Short Selling Data

Short Interest 137,110 (-89.49%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



GlaxoSmithKline plc GLAXF Financials
Period Ending Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008
Total Revenue 42,563,000 44,452,000 45,810,000 35,259,261
Cost of Revenue 11,395,000 11,886,000 11,918,000 9,288,279
Gross Profit 31,168,000 32,566,000 33,893,000 25,970,982
Operating Expenses

Research and Development 6,230,000 6,978,000 6,631,000 5,329,720
Sales, General and Admin. 12,805,000 19,665,000 13,657,000 11,085,122
Non-Recurring Items - - - (783,314)
Other - - - -
Operating Income 12,133,000 5,923,000 13,605,000 10,339,454
Income From Continuing Operations

Add'l Income/Expense Items 1,049,000 195,000 (965,000) 453,193
Earnings Before Interest and Tax 13,206,000 6,244,000 12,743,000 10,862,146
Interest Expense 1,242,000 1,301,000 - 1,220,580
Earnings Before Tax 11,964,000 4,943,000 12,743,000 9,641,566
Income Tax 3,481,000 2,042,000 3,588,000 2,819,061
Minority Interest 306,000 343,000 223,000 -
Equity Earnings Unconsolidated Subsidiary 23,000 127,000 103,000 69,499
Net Income Cont. Operations 8,200,000 2,685,000 9,035,000 6,822,505
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 8,200,000 2,685,000 8,932,000 6,822,505
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 8,176,000 2,558,000 8,932,000 6,822,505

GlaxoSmithKline plc GLAXF Recent News

Oct 8, 2013 Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development
Oct 8, 2013 Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline
Oct 7, 2013 Isis Earns $7 Million in Milestone Payments from GSK for Advancement of ISIS-GSK3 Rx to Treat Viral Infection
Oct 4, 2013 Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA
Oct 4, 2013 Society for Clinical Research Sites Experiences Extraordinary Response to Global Impact Partner Program; Pfizer, GSK, Quintiles, and More to Join SCRS' Commitment to Site Success
Oct 4, 2013 Prosensa to Host Conference Call to Discuss Recent Drisapersen Data Presentations
Oct 3, 2013 Karyopharm Therapeutics Announces Appointment of Garen Bohlin to Board of Directors
Sept 30, 2013 Drug Approvals, Trial Results, and Collaboration- Research Report on Johnson & Johnson, Bristol-Myers Squibb, Eli Lilly, AbbVie, and GSK
Sept 26, 2013 The Zacks Analyst Blog Highlights:JPMorgan Chase, Fannie Mae, Freddie Mac, GlaxoSmithKline and Varian Medical System
Sept 25, 2013 Drug Recommendations, Presentations, Marketing Authorizations, and Board Appointments - Research Report on Johnson & Johnson, Lilly, Sanofi, GSK, and Pacira

1
2
3
4
5
6
7
8
next >
last >>

GLAXF GlaxoSmithKline plc Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GLAXF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GLAXF/quote
Stock Chart http://www.otcmarkets.com/stock/GLAXF/chart
Company Info http://www.otcmarkets.com/stock/GLAXF/company-info
Recent News http://www.otcmarkets.com/stock/GLAXF/news
Financials http://www.otcmarkets.com/stock/GLAXF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GLAXF/filings
Short Sales http://www.otcmarkets.com/stock/GLAXF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GLAXF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GLAXF/research
Summary http://finance.yahoo.com/q?s=GLAXF
Historical Prices http://finance.yahoo.com/q/hp?s=GLAXF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GLAXF
Basic Chart http://finance.yahoo.com/q/bc?s=GLAXF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GLAXF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GLAXF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GLAXF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GLAXF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GLAXF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GLAXF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GLAXF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GLAXF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GLAXF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GLAXF
Balance Sheet http://finance.yahoo.com/q/bs?s=GLAXF
Cash Flow http://finance.yahoo.com/q/cf?s=GLAXF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GLAXF
Market Watch http://www.marketwatch.com/investing/stock/GLAXF
Bloomberg http://www.bloomberg.com/quote/GLAXF:US
Morningstar http://quotes.morningstar.com/stock/s?t=GLAXF
Bussinessweek http://investing.businessweek.com/research/st...cker=GLAXF
Barchart http://www.barchart.com/quotes/stocks/GLAXF
OTC Short Report http://otcshortreport.com/index.php?index=GLAXF
Investopedia http://www.investopedia.com/markets/stocks/GLAXF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Zadarma Unveils Innovative Multilingual AI Voice Assistant

Updated Category News Views 106

Introducing the Zadarma AI Voice Agent Zadarma, recognized for its exceptional VoIP services, has introduced an innovative virtual assistant - the Zadarma AI Voice Agent. This cutting-edge tool is designed to revolutionize customer interactions by providing seamless call handling, whether during traditional business hours or after hours. 24/7 Customer Support The Zadarma...

Continue Reading
Exploring Shift4 Payments Inc.'s P/E Ratio Trends and Insights

Updated Category News Views 199

Analyzing Shift4 Payments Inc. Stock Performance Shift4 Payments Inc. (NYSE: FOUR) is currently valued at $93.44, reflecting a decrease of 1.22% in today’s trading session. Despite this minor drop, there is good news: over the last month, the stock has climbed by 7.41%, and impressively, it has surged by 102.95% within the past year. This rapid appreciation has led many...

Continue Reading
SkyWest Insider Sells $2.01 Million Worth of Shares

Updated Category News Views 97

Wade J Steel Executes Major Sell Order of SkyWest Stock A significant insider transaction has come to light with Wade J Steel, Chief Commercial Officer at SkyWest (NASDAQ: SKYW), recently selling shares of the company worth $2.01 million. This transaction was documented through the latest SEC filing. Understanding the Sale The SEC filing revealed that Steel sold a total...

Continue Reading
Marpai Inc. to Discuss 2024 Financial Results in Upcoming Webcast

Updated Category News Views 140

Marpai Inc. Announces Webcast for Financial Results Marpai, Inc. is set to hold a conference call and webcast aimed at presenting vital operational and financial details surrounding its results for 2024. They are a leading technology platform company, operating as a respected Third-Party Administrator (TPA) within the health insurance sector. Marpai actively works to...

Continue Reading
Marex Group Investors Urged to Act Ahead of Critical Deadline

Updated Category News Views 160

Understanding the Legal Landscape for Marex Group Investors As an investor in Marex Group plc (NASDAQ: MRX), it's essential to stay informed and proactive regarding upcoming legal proceedings that may affect your investments. The Rosen Law Firm, a global leader in investor rights, has announced an important deadline for shareholders who purchased securities during a...

Continue Reading